Sphera Funds Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-60,000
Closed -$10M 138
2018
Q2
$10M Hold
60,000
1.38% 17
2018
Q1
$10.1M Hold
60,000
1.53% 16
2017
Q4
$9.81M Hold
60,000
1.15% 19
2017
Q3
$12.3M Buy
+60,000
New +$14M 1.75% 12
2016
Q4
Sell
-70,000
Closed -$16.1M 128
2016
Q3
$16.1M Sell
70,000
-25,000
-26% -$6.11M 2.62% 6
2016
Q2
$22M Sell
95,000
-5,000
-5% -$1.15M 5.7% 2
2016
Q1
$26.8M Hold
100,000
5.81% 6
2015
Q4
$31.3M Sell
100,000
-77,100
-44% -$23M 4.58% 6
2015
Q3
$48.1M Hold
177,100
6.14% 2
2015
Q2
$53.7M Sell
177,100
-15,000
-8% -$4.47M 5.26% 2
2015
Q1
$57.2M Buy
192,100
+85,000
+79% +$24.2M 5.95% 3
2014
Q4
$27.6M Sell
107,100
-15,000
-12% -$3.75M 4.7% 2
2014
Q3
$29.5M Buy
+122,100
New +$27.3M 3.64% 6

Other funds holding AGN

Sphera Funds Management's AGN Position: Q3 2018 in Review

Sphera Funds Management sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 60,000 shares — an estimated $10M sold.

Sphera Funds Management first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $57.2M in Q1 2015. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Sphera Funds Management reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Sphera Funds Management sold 60,000 Allergan plc shares in Q3 2018, an estimated $10M.
  • Sphera Funds Management first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Sphera Funds Management's Allergan plc position peaked at $57.2M in Q1 2015.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Sphera Funds Management's 13F filing for Q3 2018, filed 14 Nov 2018.